Viracta Therapeutics Inc (VIRX)
0.8299
+0.02
(+2.44%)
USD |
NASDAQ |
May 17, 16:00
0.8299
0.00 (0.00%)
After-Hours: 20:00
Viracta Therapeutics Total Assets (Quarterly): 41.33M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 41.33M |
| December 31, 2023 | 56.69M |
| September 30, 2023 | 66.44M |
| June 30, 2023 | 76.86M |
| March 31, 2023 | 85.78M |
| December 31, 2022 | 95.99M |
| September 30, 2022 | 82.20M |
| Date | Value |
|---|---|
| June 30, 2022 | 89.16M |
| March 31, 2022 | 98.39M |
| December 31, 2021 | 108.55M |
| September 30, 2021 | 116.54M |
| June 30, 2021 | 128.68M |
| March 31, 2021 | 136.21M |
| December 31, 2020 | 48.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
41.33M
Minimum
Mar 2024
136.21M
Maximum
Mar 2021
87.94M
Average
87.47M
Median
Total Assets (Quarterly) Benchmarks
| XOMA Corp | 219.42M |
| Organovo Holdings Inc | 8.881M |
| Marinus Pharmaceuticals Inc | 137.35M |
| Cartesian Therapeutics Inc | 325.21M |
| Adial Pharmaceuticals Inc | 4.737M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 30.25M |
| Shareholders Equity (Quarterly) | 11.08M |